SEK 0.66
(1.23%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.00 SEK | -100.0% |
2022 | 2.01 Million SEK | -6.23% |
2021 | 2.15 Million SEK | 0.0% |
2020 | - SEK | -100.0% |
2019 | 1.00 SEK | 100.0% |
2018 | -32.4 Thousand SEK | 99.72% |
2017 | -11.58 Million SEK | -787.13% |
2016 | -1.3 Million SEK | -10.08% |
2015 | -1.18 Million SEK | 0.0% |
2014 | - SEK | 0.0% |
2013 | - SEK | 0.0% |
2012 | - SEK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - SEK | -100.0% |
2024 Q2 | -5.6 Million SEK | 0.0% |
2023 Q4 | 1.00 SEK | 100.0% |
2023 FY | 1.00 SEK | -100.0% |
2023 Q1 | 2.34 Million SEK | 16.12% |
2023 Q2 | -6.58 Million SEK | -381.16% |
2023 Q3 | -5.91 Million SEK | 10.13% |
2022 FY | 2.01 Million SEK | -6.23% |
2022 Q4 | 2.01 Million SEK | 58.37% |
2022 Q3 | 1.27 Million SEK | -20.24% |
2022 Q2 | 1.59 Million SEK | 3.7% |
2022 Q1 | 1.53 Million SEK | -28.42% |
2021 Q2 | 1.98 Million SEK | 3331955097600100.0% |
2021 Q3 | 1.31 Million SEK | -33.94% |
2021 Q4 | 2.15 Million SEK | 63.87% |
2021 FY | 2.15 Million SEK | 0.0% |
2021 Q1 | - SEK | 0.0% |
2020 Q4 | - SEK | 0.0% |
2020 FY | - SEK | -100.0% |
2020 Q3 | - SEK | -100.0% |
2020 Q2 | - SEK | 0.0% |
2020 Q1 | - SEK | 0.0% |
2019 Q2 | - SEK | 0.0% |
2019 Q1 | - SEK | -100.0% |
2019 FY | 1.00 SEK | 100.0% |
2019 Q4 | - SEK | 100.0% |
2019 Q3 | -219 Thousand SEK | 0.0% |
2018 Q4 | 1.00 SEK | 0.0% |
2018 Q2 | -90 Thousand SEK | -164.71% |
2018 Q3 | - SEK | 100.0% |
2018 FY | -32.4 Thousand SEK | 99.72% |
2018 Q1 | -34 Thousand SEK | 0.0% |
2017 Q1 | -1.62 Million SEK | 0.0% |
2017 Q2 | -3.35 Million SEK | -106.71% |
2017 Q3 | -3.92 Million SEK | -16.91% |
2017 Q4 | - SEK | 100.0% |
2017 FY | -11.58 Million SEK | -787.13% |
2016 Q2 | - SEK | 0.0% |
2016 Q1 | - SEK | 0.0% |
2016 FY | -1.3 Million SEK | -10.08% |
2016 Q4 | - SEK | 0.0% |
2015 Q3 | - SEK | 0.0% |
2015 Q1 | - SEK | 0.0% |
2015 Q4 | - SEK | 0.0% |
2015 FY | -1.18 Million SEK | 0.0% |
2015 Q2 | - SEK | 0.0% |
2014 Q1 | - SEK | 0.0% |
2014 Q4 | - SEK | 0.0% |
2014 FY | - SEK | 0.0% |
2014 Q3 | - SEK | 0.0% |
2013 FY | - SEK | 0.0% |
2012 FY | - SEK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AroCell AB (publ) | 6.07 Million SEK | 100.0% |
Devyser Diagnostics AB (publ) | 20.6 Million SEK | 100.0% |
Prostatype Genomics AB (publ) | 203 Thousand SEK | 100.0% |
SenzaGen AB | 6.22 Million SEK | 100.0% |
Spermosens AB | -232 Thousand SEK | 100.0% |